Patents Assigned to Kigen Biogenics Institute Co., Ltd.
  • Patent number: 8440426
    Abstract: Disclosed is a method for producing an antimutagenic substance by using a lactic acid bacteria, which can produce the antimutagenic substance in a large quantity in an extremely simple manner and is economically advantageous; particularly a method for producing an antimutagenic substance effective for a carcinogenic substance, particularly a heterocyclic amine (HCA) which is a carcinogenic substance derived from a food, by using a lactic acid bacteria. Specifically disclosed is a method for producing an antimutagenic substance by using a lactic acid bacteria, which is characterized by suspending the lactic acid bacteria in a poorly nutrient or nutrient-free medium and leaving the lactic acid bacteria in the medium.
    Type: Grant
    Filed: April 18, 2008
    Date of Patent: May 14, 2013
    Assignee: Kigen Biogenics Institute Co., Ltd.
    Inventors: Minoru Fujita, Masaharu Nakayama, Yasuteru Nakamura, Takahiro Inoue
  • Publication number: 20100143965
    Abstract: Disclosed is a method for producing an antimutagenic substance by using a lactic acid bacterium, which can produce the antimutagenic substance in a large quantity in an extremely simple manner and is economically advantageous; particularly a method for producing an antimutagenic substance effective for a carcinogenic substance, particularly a heterocyclic amine (HCA) which is a carcinogenic substance derived from a food, by using a lactic acid bacterium. Specifically disclosed is a method for producing an antimutagenic substance by using a lactic acid bacterium, which is characterized by suspending the lactic acid bacterium in a poorly nutrient or nutrient-free medium and leaving the lactic acid bacterium in the medium.
    Type: Application
    Filed: April 18, 2008
    Publication date: June 10, 2010
    Applicant: Kigen Biogenics Institute Co., Ltd.
    Inventors: Minoru Fujita, Masaharu Nakayama, Yasuteru Nakamura, Takahiro Inoue